FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044713055> ?p ?o ?g. }

• W2044713055 endingPage "719" @default.
• W2044713055 startingPage "714" @default.
• W2044713055 abstract "Eradication of hepatitis C virus (HCV) by antiviral therapy is the treatment of choice for mixed cryoglobulinemia secondary to this infection, but many patients fail to achieve sustained viral responses and need second-line treatments. Several studies have demonstrated that the infusion of the anti-CD20 monoclonal antibody rituximab is highly effective for refractory mixed cryoglobulinemia, with a clinical response in approximately 80% of patients, although the relapse rate is high. Virtually all published studies employed a rituximab dosage of 375mg/m(2) given four times, a schedule used for treating non-Hodgkin's lymphomas. Based on a prior pilot study, we designed a phase II single-arm two-stage study (EUDRACT n. 2008-000086-38) to evaluate the efficacy of a lower dosage of rituximab, 250mg/m(2) given twice, for refractory mixed cryoglobulinemia. We present here the preliminary results in the first 27 patients enrolled. The overall response rate in 24 evaluable patients was 79%, and the mean time to relapse was 6.5months, similar to the 6.7months reported in studies with high-dose rituximab. Side effects were comparable to those seen in patients treated with high-dose. Increase of HCV viral load, reported in some high-dose studies, was not observed in our patients. Low-dose rituximab may provide a more cost/effective and possibly safer alternative for treating refractory HCV-associated mixed cryoglobulinemia." @default.
• W2044713055 created "2016-06-24" @default.
• W2044713055 creator A5011528783 @default.
• W2044713055 creator A5013897699 @default.
• W2044713055 creator A5018414791 @default.
• W2044713055 creator A5028107606 @default.
• W2044713055 creator A5029336619 @default.
• W2044713055 creator A5029966387 @default.
• W2044713055 creator A5032466668 @default.
• W2044713055 creator A5033662310 @default.
• W2044713055 creator A5034791833 @default.
• W2044713055 creator A5054791712 @default.
• W2044713055 creator A5055028093 @default.
• W2044713055 creator A5056275752 @default.
• W2044713055 creator A5063982711 @default.
• W2044713055 creator A5078090921 @default.
• W2044713055 creator A5083342213 @default.
• W2044713055 creator A5087499191 @default.
• W2044713055 date "2011-09-01" @default.
• W2044713055 modified "2023-10-01" @default.
• W2044713055 title "A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection" @default.
• W2044713055 cites W1964985725 @default.
• W2044713055 cites W1967429097 @default.
• W2044713055 cites W1986963372 @default.
• W2044713055 cites W2000677416 @default.
• W2044713055 cites W2019985783 @default.
• W2044713055 cites W2028453745 @default.
• W2044713055 cites W2035777161 @default.
• W2044713055 cites W2040537348 @default.
• W2044713055 cites W2044784043 @default.
• W2044713055 cites W2046900942 @default.
• W2044713055 cites W2060312406 @default.
• W2044713055 cites W2087164555 @default.
• W2044713055 cites W2090978265 @default.
• W2044713055 cites W2111559593 @default.
• W2044713055 cites W2111579213 @default.
• W2044713055 cites W2113311407 @default.
• W2044713055 cites W2116974590 @default.
• W2044713055 cites W2138835266 @default.
• W2044713055 cites W2141044014 @default.
• W2044713055 cites W2156343854 @default.
• W2044713055 cites W2163139441 @default.
• W2044713055 cites W34905732 @default.
• W2044713055 cites W4230989994 @default.
• W2044713055 doi "https://doi.org/10.1016/j.autrev.2011.04.033" @default.
• W2044713055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21570494" @default.
• W2044713055 hasPublicationYear "2011" @default.
• W2044713055 type Work @default.
• W2044713055 sameAs 2044713055 @default.
• W2044713055 citedByCount "66" @default.
• W2044713055 countsByYear W20447130552012 @default.
• W2044713055 countsByYear W20447130552013 @default.
• W2044713055 countsByYear W20447130552014 @default.
• W2044713055 countsByYear W20447130552015 @default.
• W2044713055 countsByYear W20447130552016 @default.
• W2044713055 countsByYear W20447130552017 @default.
• W2044713055 countsByYear W20447130552018 @default.
• W2044713055 countsByYear W20447130552019 @default.
• W2044713055 countsByYear W20447130552020 @default.
• W2044713055 countsByYear W20447130552021 @default.
• W2044713055 countsByYear W20447130552022 @default.
• W2044713055 countsByYear W20447130552023 @default.
• W2044713055 crossrefType "journal-article" @default.
• W2044713055 hasAuthorship W2044713055A5011528783 @default.
• W2044713055 hasAuthorship W2044713055A5013897699 @default.
• W2044713055 hasAuthorship W2044713055A5018414791 @default.
• W2044713055 hasAuthorship W2044713055A5028107606 @default.
• W2044713055 hasAuthorship W2044713055A5029336619 @default.
• W2044713055 hasAuthorship W2044713055A5029966387 @default.
• W2044713055 hasAuthorship W2044713055A5032466668 @default.
• W2044713055 hasAuthorship W2044713055A5033662310 @default.
• W2044713055 hasAuthorship W2044713055A5034791833 @default.
• W2044713055 hasAuthorship W2044713055A5054791712 @default.
• W2044713055 hasAuthorship W2044713055A5055028093 @default.
• W2044713055 hasAuthorship W2044713055A5056275752 @default.
• W2044713055 hasAuthorship W2044713055A5063982711 @default.
• W2044713055 hasAuthorship W2044713055A5078090921 @default.
• W2044713055 hasAuthorship W2044713055A5083342213 @default.
• W2044713055 hasAuthorship W2044713055A5087499191 @default.
• W2044713055 hasConcept C121332964 @default.
• W2044713055 hasConcept C126322002 @default.
• W2044713055 hasConcept C142424586 @default.
• W2044713055 hasConcept C142462285 @default.
• W2044713055 hasConcept C143998085 @default.
• W2044713055 hasConcept C203014093 @default.
• W2044713055 hasConcept C2522874641 @default.
• W2044713055 hasConcept C2776408679 @default.
• W2044713055 hasConcept C2776455275 @default.
• W2044713055 hasConcept C2778922544 @default.
• W2044713055 hasConcept C2779338263 @default.
• W2044713055 hasConcept C2780653079 @default.
• W2044713055 hasConcept C71924100 @default.
• W2044713055 hasConcept C87355193 @default.
• W2044713055 hasConcept C90924648 @default.
• W2044713055 hasConceptScore W2044713055C121332964 @default.
• W2044713055 hasConceptScore W2044713055C126322002 @default.
• W2044713055 hasConceptScore W2044713055C142424586 @default.
• W2044713055 hasConceptScore W2044713055C142462285 @default.

• next